Cagrilintide
Cagrilintide
About
Cagrilintide is a synthetic long-acting amylin analogue supplied as a reagent for in vitro metabolic research and preclinical laboratory models. It is studied in the context of satiety regulation, energy balance and amylin signalling.
It ships as a lyophilized powder in a glass vial carrying RUO labelling. Every batch is quality-controlled by HPLC; typical purity is ≥98–99%, making the material suitable for reproducible experimental work.
The full scientific write-up — mechanism of action, structure and physicochemical characteristics — lives in a dedicated article in our wiki, linked from this page.
Store the lyophilizate in a dry, light-protected place at low temperature; once reconstituted, follow standard cold-storage practice. For Research Use Only. Not intended for human or animal consumption; not a medicine, dietary supplement or cosmetic product.
Q&A
What is the half-life of Cagrilintide?
The half-life of cagrilintide is approximately 7 days (159–195 h) by subcutaneous administration, from the phase 1 study (Enebo et al., Lancet, 2021). See the Dosing section for detail.
DosingDosing
Adults were studied with weekly subcutaneous doses, including in combination with semaglutide 2.4 mg.
Full dosing guideTitration schedule · referenceReviews
No reviews yet
Bought this product? Be the first to tell others — it takes a minute.



